Armata Pharmaceuticals Inc (ARMP)
2.02
+0.08
(+4.12%)
USD |
NYAM |
Dec 24, 12:02
Armata Pharmaceuticals Cash from Investing (Quarterly): -0.34M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 0.334M |
| Perspective Therapeutics Inc | -29.74M |
| Protalix BioTherapeutics Inc | 20.33M |
| Electromed Inc | -0.058M |
| Xtant Medical Holdings Inc | -2.009M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.863M |
| Cash from Financing (Quarterly) | -0.061M |
| Free Cash Flow | -42.09M |
| Free Cash Flow Per Share (Quarterly) | -0.2544 |
| Free Cash Flow Yield | -50.01% |